A fortune.
You wouldn't sell prior to approval.
The product is estimating to generate around $225 million in revenue annually through the USA alone.
This is game changing based on scripts in established overseas markets.
Then you add P/E multiples against these figures and the numbers are mind blowing.
Botanix knows this is game changing, they wouldn't just give this away.
Even currently selling this under a billion dollars is a crime.
BOT - Anything but charting, page-6775
-
- There are more pages in this discussion • 2,144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $559.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 34.5¢ | $1.936M | 5.490M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 916307 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 349406 | 10 |
View Market Depth
| Last trade - 12.21pm 26/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |